Resverlogix Corp.
Records under this name other than the patents Resverlogix Corp. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 17 patents it holds.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 8,410,109 | Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices Lapsed on the fee record Ended Apr 2, 2025 · From the USPTO record | Lapsed on the fee record | Ended Apr 2, 2025 | From the USPTO record |
| US 10,882,828 | Anti-inflammatory agents Lapsed on the fee record Ended Jan 5, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jan 5, 2025 | From the USPTO record |
| US 8,242,130 | Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases Lapsed on the fee record Ended Aug 14, 2024 · From the USPTO record | Lapsed on the fee record | Ended Aug 14, 2024 | From the USPTO record |
| US 8,242,144 | Stilbenes and chalcones for the prevention and treatment of cardiovascular diseases Lapsed on the fee record Ended Aug 14, 2024 · From the USPTO record | Lapsed on the fee record | Ended Aug 14, 2024 | From the USPTO record |
| US 9,278,940 | Cyclic amines as bromodomain inhibitors Formerly held Lapsed on the fee record Ended Mar 8, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 8, 2024 | From the USPTO record |
| US 9,271,978 | Heterocyclic compounds as bromodomain inhibitors Formerly held Lapsed on the fee record Ended Mar 1, 2024 · From the USPTO record | Lapsed on the fee record | Ended Mar 1, 2024 | From the USPTO record |
| US 9,238,640 | Anti-inflammatory agents Lapsed on the fee record Ended Jan 19, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 19, 2024 | From the USPTO record |
| US 8,093,273 | Flavanoids and isoflavanoids for the prevention and treatment of cardiovascular diseases Lapsed on the fee record Ended Jan 10, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jan 10, 2024 | From the USPTO record |
| US 9,073,878 | Cyclic amines as bromodomain inhibitors Formerly held Lapsed on the fee record Ended Jul 7, 2023 · From the USPTO record | Lapsed on the fee record | Ended Jul 7, 2023 | From the USPTO record |
| US 10,231,953 | Inhibitors of bromodomains Formerly held Lapsed on the fee record Ended Mar 19, 2023 · From the USPTO record | Lapsed on the fee record | Ended Mar 19, 2023 | From the USPTO record |